MedTrace Logo

A Comparison Study of Oxybutynin and Botulinum Toxin for Neurogenic Detrusor Overactivity

NCT01477736 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2011-11-22

No results posted yet for this study

Summary

The purpose of this study is to compare the effects of oral oxybutynin and intradetrusor injections of botulinum toxin type A on urodynamic parameters and quality of life in patients with neurogenic detrusor overactivity following spinal cord injury.

Conditions

  • Spinal Cord Injury

Interventions

DRUG

Oxybutynin

5 mg of immediate-release oxybutynin orally 3 times daily

DRUG

Botulinum toxin A

300 U intradetrusor injection

Sponsors & Collaborators

  • Centro de Reabilitação e Readaptação Dr. Henrique Santillo

    lead OTHER

Principal Investigators

  • RUITER S FERREIRA, Dr. · Division of Urology of State University of Campinas, Division of Urology of Centro de Reabilitaçao e Readapatacao Dr. Henrique Santillo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01477736 on ClinicalTrials.gov